Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
Posttransplant lymphoproliferative disorder (PTLD) is a frequent complication of intestinal transplantation and is associated with a poor prognosis. There is currently no consensus on optimal therapy. Recurrent PTLD involving the central nervous system (CNS) represents a particularly difficult thera...
Main Authors: | Clare J. Twist, Ricardo O. Castillo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Case Reports in Transplantation |
Online Access: | http://dx.doi.org/10.1155/2013/765230 |
Similar Items
-
Posttransplant Lymphoproliferative Disorders
by: Hazem A. H. Ibrahim, et al.
Published: (2012-01-01) -
Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant
by: Bharat Malhotra, et al.
Published: (2015-01-01) -
A case of posttransplant lymphoproliferative disorder
by: G S Chowdhary, et al.
Published: (2017-01-01) -
Posttransplant Lymphoproliferative Disorder Involving the Gastrointestinal Tract
by: Tejas Kirtane, et al.
Published: (2020-12-01) -
Sezary syndrome manifesting as posttransplant lymphoproliferative disorder
by: Thanh-Phuong Afiat, et al.
Published: (2018-01-01)